Stoecker William V MD

Rolla, MO Doing business as The Dermatology & Aesthetic Center

UEI
UYL3F1M5BGK7
CAGE
47WU1
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Sole Proprietorship
SAM.gov registration date
Physical address
10101 Stoltz Dr, Rolla, MO 65401, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Missouri System "Objective: The objective of this research is to develop new techniques using both deep learning (convolutional neural networks, DL) and conventional… R15CA287304 $29,269
University Of Missouri System "Objective: The objective of this research is to develop new techniques using both deep learning (convolutional neural networks, DL) and conventional… R15CA287304 $99,000

Similar vendors

About the company

Stoecker William V MD, doing business as The Dermatology & Aesthetic Center, is a sole proprietorship based in Rolla, Missouri, that acts as a federal grant recipient (75% of recent awards) and sub-recipient on National Institutes of Health research programs focused on dermatology and skin cancer diagnostics. The vendor operates outside federal contracting vehicles; all federal activity flows through grant programs managed by NIH institutes.

The vendor's customer base is monolithic—all eight awards originate from the Department of Health and Human Services National Institutes of Health and its subordinate institutes (National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Nursing Research). The vendor is the principal recipient for a $2.4 million grant portfolio that centers on translational and clinical dermatology research.

As a prime grant recipient, Stoecker William V MD received a Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (award date September 15, 2021; ultimate completion August 31, 2023) to develop suramin-based therapy for Loxosceles recluse spider bites, partnering with SpiderTek, a biotechnology company, and the University of Missouri. The research proposed Phase I proof-of-concept for suramin therapy—determining effective in-vivo dosing, optimal treatment windows post-bite, and comparison of injectable versus novel topical administration routes—with planned Phase II human trials.

As a sub-recipient, the vendor contributes clinical and dermoscopy imaging, image annotation, and biomedical researcher mentoring to University of Missouri System grants focused on deep-learning and feature-based image analysis for early-stage skin cancer detection. Two sub-awards (May 1, 2024, and December 19, 2025) task the vendor with providing a minimum of 80,000 clinical and dermoscopy images with ground-truth diagnoses, pixel-level overlays for ten dermoscopy features across 2,000-plus images, and graduate-level researcher support for students in MATLAB, Python, PyTorch, and neural-network development.

Award activity is sparse and episodic—one award in 2010, 2018, 2021, 2024, and 2025—reflecting the project-grant lifecycle rather than sustained contract demand.

Quick answers

Is Stoecker William V MD registered in SAM.gov?

Yes. Stoecker William V MD's SAM.gov registration is active through September 2, 2027.

What is Stoecker William V MD's most recent federal award?

Stoecker William V MD's most recent federal grant award is Suramin for recluse spider bites: spidertek, a biotechnology company that developed the first spider bite diagnostic… (R41AR079340), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on September 15, 2021.

On GovTribe

See Stoecker William V MD's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors